Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immunodeficiency”

1,054 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,054 results

Not applicableStudy completedNCT01904994
What this trial is testing

Link4Health: A Combination Strategy for Linkage and Retention, Swaziland

Who this might be right for
HIV (Human Immunodeficiency Virus)
Columbia University 2,201
Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Not applicableStudy completedNCT00000703
What this trial is testing

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableStudy completedNCT00925795
What this trial is testing

Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients

Who this might be right for
HIVAtherosclerosisHIV Infections
University Hospital for Infectious Diseases, Croatia 39
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Early research (Phase 1)Study completedNCT00357604
What this trial is testing

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

Who this might be right for
HIV Infections
Bristol-Myers Squibb 22
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Not applicableStudy completedNCT01134939
What this trial is testing

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

Who this might be right for
HIV Infections
Boehringer Ingelheim 265
Testing effectiveness (Phase 2)Study completedNCT00958100
What this trial is testing

Raltegravir Switch for Toxicity or Adverse Events

Who this might be right for
HIV/AIDSAntiretroviral TherapyHIV Infections
Catholic University of the Sacred Heart 40
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT00002039
What this trial is testing

An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Astra USA
Early research (Phase 1)Study completedNCT02157467
What this trial is testing

Study of Combined Oral Contraceptive Effects in Female Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 46
Next Page